Diabetes drug trial aims to slow Alzheimer's by protecting brain connections
NCT ID NCT07200622
Summary
This study is testing whether a pill called oral semaglutide, currently used for diabetes, is safe and might help slow down Alzheimer's disease. Researchers will give the drug to 60 people with mild Alzheimer's for one year to see if it protects the brain's communication points (synapses) from damage. The main goal is to check for side effects, while a secondary goal uses brain scans to see if the drug helps preserve these vital connections.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALZHEIMER DISEASE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.